Copyright Reports & Markets. All rights reserved.

Global Diabetic Gastroparesis Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Diabetic Gastroparesis Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drugs
      • 1.4.3 Surgical Treatment Products
    • 1.5 Market by Application
      • 1.5.1 Global Diabetic Gastroparesis Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Private Clinics
      • 1.5.4 Drug Stores
      • 1.5.5 Retail Pharmacies
      • 1.5.6 E-Commerce
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Diabetic Gastroparesis Treatment Market Size
    • 2.2 Diabetic Gastroparesis Treatment Growth Trends by Regions
      • 2.2.1 Diabetic Gastroparesis Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Diabetic Gastroparesis Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Diabetic Gastroparesis Treatment Market Size by Manufacturers
      • 3.1.1 Global Diabetic Gastroparesis Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Diabetic Gastroparesis Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Diabetic Gastroparesis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Diabetic Gastroparesis Treatment Key Players Head office and Area Served
    • 3.3 Key Players Diabetic Gastroparesis Treatment Product/Solution/Service
    • 3.4 Date of Enter into Diabetic Gastroparesis Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Diabetic Gastroparesis Treatment Market Size by Type (2014-2019)
    • 4.2 Global Diabetic Gastroparesis Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 5.2 Diabetic Gastroparesis Treatment Key Players in United States
    • 5.3 United States Diabetic Gastroparesis Treatment Market Size by Type
    • 5.4 United States Diabetic Gastroparesis Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 6.2 Diabetic Gastroparesis Treatment Key Players in Europe
    • 6.3 Europe Diabetic Gastroparesis Treatment Market Size by Type
    • 6.4 Europe Diabetic Gastroparesis Treatment Market Size by Application

    7 China

    • 7.1 China Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 7.2 Diabetic Gastroparesis Treatment Key Players in China
    • 7.3 China Diabetic Gastroparesis Treatment Market Size by Type
    • 7.4 China Diabetic Gastroparesis Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 8.2 Diabetic Gastroparesis Treatment Key Players in Japan
    • 8.3 Japan Diabetic Gastroparesis Treatment Market Size by Type
    • 8.4 Japan Diabetic Gastroparesis Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 9.2 Diabetic Gastroparesis Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Diabetic Gastroparesis Treatment Market Size by Type
    • 9.4 Southeast Asia Diabetic Gastroparesis Treatment Market Size by Application

    10 India

    • 10.1 India Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 10.2 Diabetic Gastroparesis Treatment Key Players in India
    • 10.3 India Diabetic Gastroparesis Treatment Market Size by Type
    • 10.4 India Diabetic Gastroparesis Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Diabetic Gastroparesis Treatment Market Size (2014-2019)
    • 11.2 Diabetic Gastroparesis Treatment Key Players in Central & South America
    • 11.3 Central & South America Diabetic Gastroparesis Treatment Market Size by Type
    • 11.4 Central & South America Diabetic Gastroparesis Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Janssen Global Services
      • 12.1.1 Janssen Global Services Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Diabetic Gastroparesis Treatment Introduction
      • 12.1.4 Janssen Global Services Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.1.5 Janssen Global Services Recent Development
    • 12.2 Evoke Pharma
      • 12.2.1 Evoke Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Diabetic Gastroparesis Treatment Introduction
      • 12.2.4 Evoke Pharma Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.2.5 Evoke Pharma Recent Development
    • 12.3 Cardinal Health
      • 12.3.1 Cardinal Health Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Diabetic Gastroparesis Treatment Introduction
      • 12.3.4 Cardinal Health Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.3.5 Cardinal Health Recent Development
    • 12.4 Salix Pharmaceuticals
      • 12.4.1 Salix Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Diabetic Gastroparesis Treatment Introduction
      • 12.4.4 Salix Pharmaceuticals Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.4.5 Salix Pharmaceuticals Recent Development
    • 12.5 Alfa Wassermann
      • 12.5.1 Alfa Wassermann Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Diabetic Gastroparesis Treatment Introduction
      • 12.5.4 Alfa Wassermann Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.5.5 Alfa Wassermann Recent Development
    • 12.6 Abbott Laboratories
      • 12.6.1 Abbott Laboratories Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Diabetic Gastroparesis Treatment Introduction
      • 12.6.4 Abbott Laboratories Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.6.5 Abbott Laboratories Recent Development
    • 12.7 Medtronic
      • 12.7.1 Medtronic Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Diabetic Gastroparesis Treatment Introduction
      • 12.7.4 Medtronic Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.7.5 Medtronic Recent Development
    • 12.8 C.R.Bard
      • 12.8.1 C.R.Bard Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Diabetic Gastroparesis Treatment Introduction
      • 12.8.4 C.R.Bard Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.8.5 C.R.Bard Recent Development
    • 12.9 Rhythm Pharmaceuticals
      • 12.9.1 Rhythm Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Diabetic Gastroparesis Treatment Introduction
      • 12.9.4 Rhythm Pharmaceuticals Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.9.5 Rhythm Pharmaceuticals Recent Development
    • 12.10 Boston Scientific
      • 12.10.1 Boston Scientific Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Diabetic Gastroparesis Treatment Introduction
      • 12.10.4 Boston Scientific Revenue in Diabetic Gastroparesis Treatment Business (2014-2019)
      • 12.10.5 Boston Scientific Recent Development
    • 12.11 Kimberly-Clark

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Delayed gastric emptying associated with diabetes is known as Diabetic Gastroparesis (DGP). Though it occurs in patients suffering from both Type-1 and Type- 2 diabetes, it is more common in female patients suffering from Type-2 diabetes. The cause of DGP is inherent damage in the vagus nerve that controls the movement of food through the digestive tract.
      Factors such as rising prevalence of diabetic gastroparesis with high unmet medical needs and availability of reimbursement for in-patient hospital stays in developed countries are expected to drive growth of the global diabetic gastroparesis treatment market over the forecast period. Increasing use of diabetic gastroparesis drugs to control symptoms such as nausea and vomiting is anticipated to fuel growth of the global diabetic gastroparesis treatment market over the forecast period. Also, increasing affordability among people and easy access to medicines are further expected to boost market revenue growth over the forecast period. However, usage of non-prescription drugs to control the symptoms restricts diagnosis of stage 1 and stage 2 gastroparesis. Lack of clinical evidence on improvement offered by prescription drugs and termination of clinical trials are factors expected to hamper growth of the global diabetic gastroparesis treatment market over the forecast period.
      In 2018, the global Diabetic Gastroparesis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Diabetic Gastroparesis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Gastroparesis Treatment development in United States, Europe and China.

      The key players covered in this study
      Janssen Global Services
      Evoke Pharma
      Cardinal Health
      Salix Pharmaceuticals
      Alfa Wassermann
      Abbott Laboratories
      Medtronic
      C.R.Bard
      Rhythm Pharmaceuticals
      Boston Scientific
      Kimberly-Clark

      Market segment by Type, the product can be split into
      Drugs
      Surgical Treatment Products

      Market segment by Application, split into
      Hospital Pharmacies
      Private Clinics
      Drug Stores
      Retail Pharmacies
      E-Commerce

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Diabetic Gastroparesis Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Diabetic Gastroparesis Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Diabetic Gastroparesis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now